glutathione switch persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Tolerant/Persister Cancer Cells and the
Tolerant Persister Cancer Cells and the Path to Resistance to Targeted Therapy Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition PMC Real Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function ScienceDirect
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



